Dear Readers,
The HS Talks - Biomedical & Life Sciences Collection's new seminars are covering, a broad range of scientific knowledge held by lear researchers of the subject areas. To see them check out visit the links below.
The following new interviews have been released lately on SARS-CoV-2 RNA, Medical wearable devices, Risk of re-emergence, vaccine development, plasma therapy, Immune responses, virology.
Predicting COVID-19 outbreaks by measuring SARS-CoV-2 RNA in sewage sludge
Prof. Jordan Peccia Yale University, USA
Medical wearable devices for tracking symptoms of COVID-19
Prof. John Rogers Northwestern University, USA
The evolutionary origin of SARS-CoV-2
Dr. Feng Gao Duke University Medical Center, USA
Risk of re-emergence of COVID-19 after exit from lockdown
Dr. Leonardo Lopez Barcelona Institute for Global Health, Spain
Challenges of accelerated vaccine development
Dr. Jakub Simon Director of Clinical Research, Vaccines, Merck Research Laboratories, USA
Convalescent plasma therapy as a treatment for COVID-19
Dr. Manu Shankar-Hari NIHR Clinician Scientist & Consultant in ICM, Guy's and St Thomas' NHS Foundation Trust., UK
Immune responses to viruses
Prof. Paul Klenerman University of Oxford, UK
Remdesivir COVID-19 clinical trial
Prof. Mahesh Parmar University College London, UK
SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
The development of SARS-CoV-2 vaccines
Prof. Peter Hotez Baylor College of Medicine, USA
Principles of virology
Prof. Vincent Racaniello Columbia University, USA
Nanotechnologies in the fight against coronaviruses
Prof. Sabine Szunerits University of Lille, France
Introduction to the immune system
Prof. Herman Waldmann University of Oxford, UK
Hematopoiesis: the making of an immune system
Prof. Paul J. Fairchild University of Oxford, UK
Regulated cell death mechanisms and their crosstalk with the immune system 1
Dr. Luis Alberto Baena-Lopez University of Oxford, UK
Regulated cell death mechanisms and their crosstalk with the immune system 2
Dr. Luis Alberto Baena-Lopez University of Oxford, UK
The immunology of multiple sclerosis
Dr. Joanne Jones University of Cambridge, UK
MRD driven multiple myeloma treatment: next step forward
Prof. Ola Landgren Memorial Sloan Kettering Cancer Center, USA
Fundamentals of protein chromatography: basic protein purification
Emeritus Prof. Richard R. Burgess University of Wisconsin-Madison, USA
Fundamentals of protein chromatography: protein chromatography
Emeritus Prof. Richard R. Burgess University of Wisconsin-Madison, USA
Mosaicism
Prof. Eamonn Maher University of Cambridge, UK
Darwin's legacy: evolutionary interactions
Prof. Vassiliki Betty Smocovitis University of Florida, USA
Tolerance induction to clotting factors with monoclonal antibodies
Prof. Luís Graça University of Lisbon, Portugal
Schistosomiasis
Prof. Russel Stothard Liverpool School of Tropical Medicine, UK
Hard tissue biology in human health and evolution: craniofacial biology
Prof. Timothy Bromage New York University, USA
Liver and spleen
Emeritus Prof. Kapil S. Satyapal University of KwaZulu-Natal, South Africa
Approaches for elucidating genetic susceptibility to SARS-CoV-2
Dr. Kenneth Baillie University of Edinburgh, UK
Human challenge trials for vaccines against COVID-19
Prof. Peter Smith London School of Hygiene & Tropical Medicine, UK
The immune system response to the SARS-CoV-2 virus: July 2020 update
Prof. Paul Klenerman University of Oxford, UK
The impact of COVID-19 in the elderly and in care homes
Dr. David Strain University of Exeter Medical School, UK
Remdesivir COVID-19 clinical trial
Prof. Mahesh Parmar University College London, UK
The development of SARS-CoV-2 vaccines
Prof. Peter Hotez Baylor College of Medicine, USA
Nanotechnologies in the fight against coronaviruses
Prof. Sabine Szunerits University of Lille, France
Convalescent plasma therapy as a treatment for COVID-19
Dr. Manu Shankar-Hari NIHR Clinician Scientist & Consultant in ICM, Guy's and St Thomas' NHS Foundation Trust., UK
INFβ therapy for COVID-19: the new SNG001 drug
Prof. Stephen Holgate University of Southampton, UK
The immunogenicity problem in antibody therapy
Prof. Herman Waldmann University of Oxford, UK
Successes and failures with vaccines
Prof. Stanley Plotkin University of Pennsylvania, USA
The immune system response to the SARS-CoV-2 virus: an update
Prof. Paul Klenerman University of Oxford, UK
SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
Novel approaches to diagnosis of viral infections
Prof. W. Ian Lipkin Columbia University, USA
Implementation of adaptive methods in early phase clinical trials
Prof. Gina Petroni University of Virginia, USA
Inorganic nanostructured interfaces for therapeutic delivery
Prof. Tejal Desai University of California, San Francisco, USA
Vaccine delivery
Prof. Sevda Şenel Hacettepe University, Turkey
Intravenous immunoglobulins: clinical evidence
Prof. Shaye Kivity Sheba Medical Center, Israel
A primer on cancer genetics
Dr. Marc Tischkowitz University of Cambridge, UK
Genetic testing: prediction vs. risk
Dr. Giles Yeo University of Cambridge, UK
Mitochondria in health and disease
Prof. Eamonn Maher University of Cambridge, UK
Challenges of accelerated vaccine development
Dr. Jakub Simon Director of Clinical Research, Vaccines, Merck Research Laboratories, USA
Targeting the cancer microenvironment: inflammatory breast cancer management
Prof. Naoto T. Ueno The University of Texas MD Anderson Cancer Center, USA
Introduction to the peripheral nervous system
Prof. Samuel Asala University of Abuja, Nigeria
Monoclonal antibodies in haemato-oncology
Prof. Mark Cragg University of Southampton, UK
Biologic therapy of rheumatoid arthritis
Prof. John Isaacs Newcastle University, UK
Rheumatoid arthritis 1
Prof. Peter C. Taylor University of Oxford, UK
Rheumatoid arthritis 2
Prof. Peter C. Taylor University of Oxford, UK
Reproductive immunology
Prof. Gil Mor Wayne State University, USA
Sensory processing: a critical area for understanding autism spectrum disorders
Prof. Winnie Dunn University of Missouri, USA
Biased signaling at mu opioid receptor splice variants
Prof. Ying-Xian Pan Memorial Sloan-Kettering Cancer Center, USA
INFβ therapy for COVID-19: the new SNG001 drug
Prof. Stephen Holgate University of Southampton, UK
Strategies for exiting the lockdown
Prof. David McCoy Queen Mary University of London, UK
SARS-CoV-2 human monoclonal antibody therapy
Prof. James Crowe Vanderbilt Vaccine Center, USA
An FDA approved salivary test for SARS-CoV-2 infection
Prof. Andrew Brooks Rutgers University, USA
The COVID-19 coronavirus outbreak: May 2020 update
Prof. Jonathan Temte University of Wisconsin, USA
Strategies for exiting the lockdown
Prof. David McCoy Queen Mary University of London, UK
INFβ therapy for COVID-19: the new SNG001 drug
Prof. Stephen Holgate University of Southampton, UK
SARS-CoV-2 human monoclonal antibody therapy
Prof. James Crowe Vanderbilt Vaccine Center, USA
The COVID-19 coronavirus outbreak: May 2020 update
Prof. Jonathan Temte University of Wisconsin, USA
Antiviral drugs (non-HIV)
Prof. Megan Shaw Mount Sinai, USA
The type I interferon system and viruses
Dr. Adolfo Garcia-Sastre Icahn School of Medicine at Mount Sinai, USA
The immunogenicity problem in antibody therapy
Prof. Herman Waldmann University of Oxford, UK
Antibody engineering: beginnings to bispecifics and beyond
Dr. Ian Wilkinson Absolute Antibody, UK
Phage display for generating monoclonal antibodies
Dr. Andre Frenzel YUMAB GMBH, Germany
Usage of vaccines and therapeutics in public health emergencies 1
Prof. Gary Kobinger Laval University, Canada
The COVID-19 coronavirus outbreak: a follow-up interview - (open access)
Prof. Jonathan Temte University of Wisconsin, USA
SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
COVID-19 epidemiology and potential treatments: follow up interview - (open access)
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
Principles of virology
Prof. Vincent Racaniello Columbia University, USA
Immune responses to viruses
Prof. Paul Klenerman University of Oxford, UK
Fundamentals of HIV biology
Prof. Viviana Simon Icahn School of Medicine at Mount Sinai, USA
Cytomegalovirus biology
Prof. Domenico Tortorella Icahn School of Medicine at Mount Sinai, USA
Binding kinetics in drug discovery
Dr. Rumin Zhang VP of Discovery, Rafael Pharmaceuticals, USA
Subarachnoid hemorrhage (SAH)
Prof. R. Loch Macdonald University of San Francisco, USA
Treating diabetes in the elderly: overcoming challenges
Dr. David Strain University of Exeter Medical School, UK
Ethnic variation in the susceptibility to diabetes
Prof. Jonathan Shaw Baker IDI Heart and Diabetes Institute, Australia
Disorders of gastric function: gastroparesis and functional dyspepsia 1
Dr. Braden Kuo Harvard Medical School, USA
Disorders of gastric function: gastroparesis and functional dyspepsia 2
Dr. Braden Kuo Harvard Medical School, USA
Pediatric stroke: cerebrovascular injury in the developing brain
Prof. Adam Kirton University of Calgary, Canada
Prevention: carotid endarterectomy, angioplasty, and stenting
Prof. Brian Hoh University of Florida, USA
Measles
Prof. Diane E. Griffin Johns Hopkins Bloomberg School of Public Health, USA
Chagas disease
Prof. Peter Hotez Baylor College of Medicine, USA
The immune system response to the SARS-COV-2 virus: an update
Prof. Paul Klenerman University of Oxford, UK
Development of an intranasal vaccine for SARS-CoV-2
Dr. Scot Roberts CSO, Altimmune, USA
Development of PRO-140 (Leronlimab) as a treatment for COVID-19
Dr. Jacob Lalezari Quest Clinical Research, USA
COVID-19 epidemiology and potential treatments: follow up interview
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
COVID-19 epidemiology and potential treatments: follow up interview - (open access)
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
Development of PRO-140 (Leronlimab) as a treatment for COVID-19 - (open access)
Dr. Jacob Lalezari Quest Clinical Research, USA
The impact of genomic architecture and diversity on infectious diseases
Prof. Vincent Chow National University of Singapore, Singapore
Antiviral drugs (non-HIV)
Prof. Megan Shaw Mount Sinai, USA
Novel approaches to diagnosis of viral infections
Prof. W. Ian Lipkin Columbia University, USA
The type I interferon system and viruses
Dr. Adolfo Garcia-Sastre Icahn School of Medicine at Mount Sinai, USA
HIV cure: harnessing innate and adaptive strategies
Prof. Luis Montaner The Wistar Institute, USA
SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
The COVID-19 outbreak: an update on the SARS-CoV-2 virus - (open access)
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
The COVID-19 coronavirus outbreak: a follow-up interview - (open access)
Prof. Jonathan Temte University of Wisconsin, USA
SARS-CoV-2 vaccine development - (open access)
Prof. Stanley Plotkin University of Pennsylvania, USA
SARS-COV-2: What we need to know and possible future therapies - (open access)
Prof. Stanley Perlman University of Iowa, USA
SARS-COV-2: What we need to know and possible future therapies - (open access)
Prof. Stanley Perlman University of Iowa, USA
SARS-COV-2 vaccine development: where are we now? - (open access)
Prof. Gary Kobinger Laval University, Canada
The current understanding of the biology of the SARS-COV-2 virus - (open access)
Prof. Peter Palese Mount Sinai School of Medicine, USA
SARS-COV-2 vaccine: current biological targets and considerations - (open access)
Dr. Adolfo Garcia-Sastre Icahn School of Medicine at Mount Sinai, USA
The paediatric response to the SARS-COV-2 virus and what we can learn from it - (open access)
Prof. Sallie Permar Duke University Medical School, USA
The COVID-19 coronavirus outbreak: a follow-up interview - (open access)
Prof. Jonathan Temte University of Wisconsin, USA
SARS-CoV-2 vaccine development - (open access)
Prof. Stanley Plotkin University of Pennsylvania, USA
The immune system response to the SARS-COV-2 virus - (open access)
Prof. Paul Klenerman University of Oxford, UK
SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
Emerging or newly discovered viral causes of acute lower respiratory tract infections worldwide
Dr. Marietjie Venter NICD, South Africa
Usage of vaccines and therapeutics in public health emergencies 1
Prof. Gary Kobinger Laval University, Canada
Novel approaches to diagnosis of viral infections
Prof. W. Ian Lipkin Columbia University, USA
Mitochondrial diseases: an update
Dr. Ayesha Saleem University of Manitoba, Canada
The mast cells: the mastermind cells of the allergic inflammatory reaction
Prof. Adrian Piliponsky University of Washington, USA
Eosinophil functions in allergic diseases: an evolving paradigm
Prof. Lisa A. Spencer University of Colorado School of Medicine, USA
The role of basophils in allergy
Prof. Franco H. Falcone Justus Liebig University Giessen, Germany
An introduction to autism and the autism spectrum
Prof. Fred Volkmar Yale University School of Medicine, USA
The epidemiology of autism spectrum disorders: history and current estimates
Prof. Eric Fombonne Oregon Health and Science University, USA
The epidemiology of autism spectrum disorders: time trends and world perspectives
Prof. Eric Fombonne Oregon Health and Science University, USA
Assessment and diagnosis of individuals with Autism Spectrum Disorder (ASD)
Dr. Julie M. Wolf Yale Child Study Center, USA
Plant-soil feedbacks
Dr. Ciska Veen Netherlands Institute of Ecology, Netherlands
Cholesterol oxidation between health and disease
Prof. Giuseppe Poli University of Torino, Italy
Tropical snakebite
Prof. Robert Harrison Liverpool School of Tropical Medicine, UK
Innovative and effective subject randomization methods
Prof. Wenle Zhao Medical University of South Carolina, USA
The COVID-19 outbreak: an update on the SARS-CoV-2 virus
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
The immune system response to the SARS-COV-2 virus
Prof. Paul Klenerman University of Oxford, UK
The current understanding of the biology of the SARS-COV-2 virus
Prof. Peter Palese Mount Sinai School of Medicine, USA
The paediatric response to the SARS-COV-2 virus and what we can learn from it
Prof. Sallie Permar Duke University Medical School, USA
The COVID-19 coronavirus outbreak: a follow-up interview
Prof. Jonathan Temte University of Wisconsin, USA
The COVID-19 coronavirus outbreak: a current view
Prof. Jonathan Temte University of Wisconsin, USA
The immune system response to the SARS-COV-2 virus
Prof. Paul Klenerman University of Oxford, UK
The immune system: an overview - innate immunity
Prof. Shiv Pillai Harvard Medical School, USA
The immune system: an overview - adaptive immunity
Prof. Shiv Pillai Harvard Medical School, USA
The complement system - an introduction for undergraduates
Prof. Michael Holers University of Colorado School of Medicine, USA
Vaccine delivery
Prof. Sevda Şenel Hacettepe University, Turkey
Biodefense challenges
Dr. David Franz US Army (Retired) and Kansas State University., USA
History of vaccines
Prof. Stanley Plotkin University of Pennsylvania, USA
Successes and failures with vaccines
Prof. Stanley Plotkin University of Pennsylvania, USA
The COVID-19 outbreak: an update on the SARS-CoV-2 virus - (open access)
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
Vaccine delivery
Prof. Sevda Şenel Hacettepe University, Turkey
The COVID-19 coronavirus outbreak: a current view - (open access)
Prof. Jonathan Temte University of Wisconsin, USA
SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
Vaccine adjuvants 1
Dr. Derek O'Hagan GSK Vaccine Research, USA